About Daclizumab
Class: | Monoclonal antibody (immunosuppressant)
Use: | Prevention of acute rejection in kidney transplantation
Adult dose: | 1 mg/kg IV once every 14 days for 5 doses, starting on the day of transplantation
Pediatric dose: | Not established; safety and efficacy in pediatric patients have not been determined
Side effects: | Hypersensitivity reactions, infections, nausea, diarrhea, headache, elevated liver enzymes
Contraindications: | Hypersensitivity to daclizumab or any component of t
Drug Class
Monoclonal antibody (immunosuppressant)
Uses & Indications
Prevention of acute rejection in kidney transplantation
Storage Requirements
Store at 2°C to 8°C (36°F to 46°F); do not freeze; protect from light
Manufacturer & Packaging
Manufacturer: F. Hoffmann-La Roche Ltd., SWITZERLAND
Package Size
5ml Vial
Price & Supplier
Price in UAE: AED 2578.50
Dosage Information
Adult Dose
1 mg/kg IV once every 14 days for 5 doses, starting on the day of transplantation
Pediatric Dose
Not established; safety and efficacy in pediatric patients have not been determined
Side Effects
Hypersensitivity reactions, infections, nausea, diarrhea, headache, elevated liver enzymes
Contraindications & Precautions
Hypersensitivity to daclizumab or any component of the formulation; active infections; pregnancy
Important Warnings
Risk of serious infections, including opportunistic infections; monitor for signs of hypersensitivity; liver function tests should be monitored regularly; not recommended for use in patients with a history of autoimmune disease
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.